SCHEMBL1635154

SCHEMBL1635154

COc1cc(OC)c(/C=C/S(=O)(=O)Nc2ccc(OC)c(C(O)[C@@H](N)C(=O)O)c2)c(OC)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.42
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
PLK1 P53350 4/20 0.41
MET P08581 1/20 0.41
NQO2 P16083 1/20 0.41
FECH P22830 1/20 0.41
CLK3 P49761 1/20 0.41
CYP2D6 P10635 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA1A P35348 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
BLM P54132 1/20 0.38
KMT2A Q03164 1/20 0.38
HDAC3 O15379 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1635893 1.00 ACHE (0.42) ACHEALDH1A1LMNAPLK1MET
SCHEMBL1635250 0.89 ALDH1A1 (0.43) ACHEALDH1A1LMNAPLK1MET
SCHEMBL1635235 0.89 ALDH1A1 (0.43) ACHEALDH1A1LMNAPLK1MET
SCHEMBL1634100 0.88 ALDH1A1 (0.44) ALDH1A1LMNAPLK1METNQO2
SCHEMBL1634104 0.88 ALDH1A1 (0.44) ALDH1A1LMNAPLK1METNQO2
SCHEMBL1636427 0.85 ALDH1A1 (0.43) ALDH1A1LMNAPLK1METNQO2
SCHEMBL1636420 0.85 ALDH1A1 (0.43) ALDH1A1LMNAPLK1METNQO2
SCHEMBL1634635 0.83 ALDH1A1 (0.41) ALDH1A1LMNAPLK1METNQO2
SCHEMBL1634627 0.83 ALDH1A1 (0.41) ALDH1A1LMNAPLK1METNQO2
SCHEMBL1634011 0.82 LMNA (0.41) ALDH1A1LMNAPLK1METNQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP claimed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US claimed
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 ACHE 4839/4885ALDH1A1 564/4885LMNA 2048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.